Aldactone
Aldactone oral tablets contain 25 mg 50 mg
s lbl
Reference ID: 4230579
1 INDICATIONS AND USAGE. 1.1 Heart Failure. ALDACTONE is indicated for treatment of NYHA Class III-IV heart failure and reduced ejection fraction to.
s lbl
Food and Drug Administration Center for Drug Evaluation and
16 déc. 2020 Topic: The committee discussed spironolactone for the proposed treatment of heart failure with preserved ejection fraction (HFpEF) ...
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA
8 août 2017 on Clinical Practice Guidelines and the Heart Failure Society of America. ... ARBs for other indications may be continued on ARBs if they ...
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA
8 août 2017 on Clinical Practice Guidelines and the Heart Failure Society of America. ... ARBs for other indications may be continued on ARBs if they ...
ALDACTONE* Pfizer Canada
23 juil. 2015 Use only for "Indications": Use ALDACTONE (spironolactone) only for conditions described ... with heart failure receiving ALDACTONE.
Aldactone PM E Jul
Aldactone
Severe heart failure: The Randomized Aldactone Evaluation Study (RALES) was a and many antihypertensive drugs have additional approved indications and.
s lbl
PEDIATRIC PHARMACOTHERAPY
In children spironolactone has been used for more than 40 years to treat heart failure associated with congenital heart disease and to.
FDA Briefing Document Cardiovascular and Renal Drugs Advisory
16 déc. 2020 Spironolactone for Heart Failure with ... information supports a labeled indication for spironolactone in the treatment of adults with HFpEF ...
TOPCAT: Spironolactone vs. placebo for the treatment of heart
16 déc. 2020 If spironolactone is approved for this indication this may set a ... approval of spironolactone in treatment for heart failure with ...
- spironolactone indication heart failure